HMGB2 and polycystic ovary syndrome: We demonstrated that through gene-drug interaction network many available drugs that suggested to restore the dysregulation of lipid metabolism are efficient in correcting the abnormal gene expression of HMGB2, PDGFRA and HSD17B4 in PCOS.